Leavell Investment Management’s Edwards Lifesciences EW Stock Holding History

Leavell Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$315K	Sell	3,485 -40	-1%	-$3.35K	0.01%	524
2026 Q1	$282K	Hold	3,525	–	–	0.01%	531
2025 Q4	$301K	Hold	3,525	–	–	0.01%	497
2025 Q3	$274K	Sell	3,525 -1	-0%	-$78	0.01%	513
2025 Q2	$276K	Buy	3,526 +53	+2%	+$3.95K	0.01%	504
2025 Q1	$252K	Hold	3,473	–	–	0.01%	491
2024 Q4	$257K	Sell	3,473 -6,450	-65%	-$451K	0.01%	485
2024 Q3	$655K	Buy	9,923 +321	+3%	+$23.3K	0.03%	344
2024 Q2	$887K	Hold	9,602	–	–	0.05%	285
2024 Q1	$918K	Buy	9,602 +258	+3%	+$21.7K	0.05%	278
2023 Q4	$712K	Hold	9,344	–	–	0.05%	295
2023 Q3	$647K	Buy	9,344 +40	+0.4%	+$3.21K	0.05%	304
2023 Q2	$878K	Hold	9,304	–	–	0.06%	268
2023 Q1	$770K	Hold	9,304	–	–	0.05%	278
2022 Q4	$694K	Hold	9,304	–	–	0.05%	283
2022 Q3	$769K	Sell	9,304 -400	-4%	-$38.5K	0.06%	260
2022 Q2	$923K	Hold	9,704	–	–	0.07%	235
2022 Q1	$1.14M	Hold	9,704	–	–	0.08%	221
2021 Q4	$1.26M	Hold	9,704	–	–	0.08%	212
2021 Q3	$1.1M	Hold	9,704	–	–	0.08%	208
2021 Q2	$812K	Hold	9,704	–	–	0.07%	229
2021 Q1	$812K	Sell	9,704 -296	-3%	-$25K	0.07%	229
2020 Q4	$912K	Hold	10,000	–	–	0.08%	203
2020 Q3	$798K	Hold	10,000	–	–	0.07%	208
2020 Q2	$691K	Buy	10,000 +400	+4%	+$28.4K	0.07%	215
2020 Q1	$604K	Buy	9,600 +4,800	+100%	+$346K	0.07%	205
2019 Q4	$373K	Hold	4,800	–	–	0.03%	294
2019 Q3	$352K	Hold	4,800	–	–	0.04%	300
2019 Q2	$296K	Hold	4,800	–	–	0.03%	319
2019 Q1	$306K	Hold	4,800	–	–	0.03%	310
2018 Q4	$245K	Sell	4,800 -600	-11%	-$30.4K	0.03%	330
2018 Q3	$313K	Buy	+5,400	New	+$264K	0.03%	316

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Leavell Investment Management's EW Position: Q2 2026 in Review

Leavell Investment Management reduced its Edwards Lifesciences (EW) stake by 1.1% in Q2 2026, selling an estimated $3.35K and leaving 3,485 shares worth $315K. The position accounts for 0.01% of the portfolio, ranked #524.

Leavell Investment Management first reported a position in EW in Q3 2018 and has held it in 32 quarters since. The position peaked at $1.26M in Q4 2021. 313 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Leavell Investment Management held 3,485 shares of Edwards Lifesciences worth $315K as of Q2 2026.
Leavell Investment Management sold 40 Edwards Lifesciences shares in Q2 2026, an estimated $3.35K.
Edwards Lifesciences made up 0.01% of Leavell Investment Management's portfolio in Q2 2026, its #524 holding.
Leavell Investment Management first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 32 quarters since.
Leavell Investment Management's Edwards Lifesciences position peaked at $1.26M in Q4 2021.
313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.